Stockreport

Amylyx Pharmaceuticals Third Quarter 2024 Earnings: US$1.07 loss per share (vs US$0.31 profit in 3Q 2023) [Yahoo! Finance]

Amylyx Pharmaceuticals, Inc.  (AMLX) 
PDF US$1.07 loss per share (down from US$0.31 profit in 3Q 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period Looking ahead, revenue [Read more]